瘤学的战略风险评估:利用单剂活性来促进组合治疗的批准
Adetayo Kasim1, Marina Anastasiou2, Evangelia Loizou2
1Research Statistics, GlaxoSmithKline, Stevenage, United Kingdom.
Contemporary clinical trials communications
|January 19, 2026
概括
早期癌症试验中的单剂活性提高了组合疗法批准率. 利用先前的单一疗法疗效可以帮助重新利用架空的抗癌药物用于成功的组合治疗.
科学领域:
- 在瘤学瘤学.
- 药物开发 药物开发
- 临床试验 临床试验
背景情况:
- 研究早期瘤学试验中单剂活性与组合疗法的成功之间的相关性.
- 利用Intelligencia AI数据库分析单疗疗效对组合疗法批准率的影响.
研究的目的:
- 为了确定先前的单剂活性是否会影响联合癌症治疗的批准可能性.
- 根据单一疗法数据,确定优先考虑抗癌药物的策略,用于组合疗法.
主要方法:
- 分析了截至2024年9月12日的各种固体瘤的3896个组合治疗方案.
- 评估历史临床试验数据,重点关注客观反应率 (ORR) 作为单剂活性 (SAA) 的衡量标准.
主要成果:
- 组合计划的整体批准率为4.2%.
- 包括具有先前单一治疗批准的药物在内的计划显示,批准率为6.1%,而未经批准的药物为2.7%.
- 使用单一疗法失败药物,ORR>20%的组合方案的批准率为5.8%.
结论:
- 之前的单剂活性显著提高了组合癌症治疗的批准可能性.
- 利用单一疗法的疗效数据可以指导反癌药物的重新用途,否则可能会被丢弃.
- 这种方法提供了一个在瘤药物开发中提高优先级的策略.
相关概念视频
11:18Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
16.4K
A thoracic oncology database was developed to serve as a comprehensive repository for clinical and laboratory data for the purposes of translational research. The database will serve translational cancer researchers within the Thoracic Oncology Research Program. This database is adaptable to other cancer models, as well as other human...
16.4K
12:18DC/DC Boost Converter
58.4K
Source: Ali Bazzi, Department of Electrical Engineering, University of Connecticut, Storrs, CT.
Boost converters provide a versatile solution to stepping up DC voltages in many applications where a DC voltage needs to be increased without the need to convert it to AC, using a transformer, and then rectifying the transformer output. Boost converters are step-up converters that use an inductor as an energy storage device that supports the output with additional energy in addition to the DC input...
Boost converters provide a versatile solution to stepping up DC voltages in many applications where a DC voltage needs to be increased without the need to convert it to AC, using a transformer, and then rectifying the transformer output. Boost converters are step-up converters that use an inductor as an energy storage device that supports the output with additional energy in addition to the DC input...
58.4K
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
87.6K
The NICU Network Neurobehavioral Scale (NNNS) was developed as an assessment for the at-risk infant. The purpose of this article is to describe the NNNS, provide video examples of the NNNS procedures and discuss the ways in which the exam has been...
87.6K
01:26FDA Approved Drugs: Changes to Approved Drugs
245
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
245
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
27.8K
A novel methodology that is employed for the treatment of recurrent glioblastomas is described. This treatment approach employs the application of alternating electric tumor treating fields (TTFields), known as TTF Therapy in combination with bevacizumab, a targeted agent that is currently FDA approved as...
27.8K
05:19A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
681
Overtreatment is often administered to patients with low-risk prostate cancer; super-active surveillance can help avoid such...
681